| 000 | 01323 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511203613.0 | ||
| 264 | 0 | _c19920227 | |
| 008 | 199202s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPirmohamed, M | |
| 245 | 0 | 0 |
_aCarbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cDec 1991 |
||
| 300 |
_a741-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 |
_aCarbamazepine _xadverse effects |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOxcarbazepine |
| 650 | 0 | 4 |
_aPhenytoin _xpharmacology |
| 700 | 1 | _aGraham, A | |
| 700 | 1 | _aRoberts, P | |
| 700 | 1 | _aSmith, D | |
| 700 | 1 | _aChadwick, D | |
| 700 | 1 | _aBreckenridge, A M | |
| 700 | 1 | _aPark, B K | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 32 _gno. 6 _gp. 741-9 |
|
| 999 |
_c1774967 _d1774967 |
||